Skip to main content
Figure 1 | Journal of Neuroinflammation

Figure 1

From: Cognitive and cerebrovascular improvements following kinin B1 receptor blockade in Alzheimer’s disease mice

Figure 1

Experimental controls. (A) Western-blot analysis of bradykinin receptor 1 (B1R) pre-immune (PI) and anti-serum on kidney extracts from two wild-type (WT; 1,2) and two B1R knockout (KO; 3,4) mice. The anti-B1R antibody recognized a single band at the expected molecular weight (37 kDa), which was absent in B1R KO mice or in the presence of pre-immune serum. Dynein was used as standard. (B) Transgenic amyloid precursor protein (APP) mice featured increased expression of APP in both brain and pial vessels extracts, as measured by western blot. APP protein levels were not affected by vehicle (−) or treatment (+).

Back to article page